Abstract
Recently, the angiotensin-converting-enzyme (ACE) inhibitor lisinopril was shown to have some activity in migraine prevention (Journal Watch Feb 9 2001); thus, industry-sponsored researchers sought to determine whether an angiotensin-receptor blocker (ARB) also might be effective. In a randomized, double-blind, crossover study from Norway, 60 migraine patients were assigned …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
